- Home
- LSB vs MYNA Comparison
LSB vs MYNA Comparison
Compare LSB & MYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- MYNA
- Stock Information
- Founded
- LSB 2002
- MYNA 2009
- Country
- LSB China
- MYNA Germany
- Employees
- LSB N/A
- MYNA N/A
- Industry
- LSB
- MYNA
- Sector
- LSB
- MYNA
- Exchange
- LSB NYSE
- MYNA Nasdaq
- Market Cap
- LSB 41.2M
- MYNA 35.9M
- IPO Year
- LSB N/A
- MYNA 2021
- Fundamental
- Price
- LSB $2.71
- MYNA $1.36
- Analyst Decision
- LSB
- MYNA
- Analyst Count
- LSB 0
- MYNA 0
- Target Price
- LSB N/A
- MYNA N/A
- AVG Volume (30 Days)
- LSB 82.0K
- MYNA 35.5K
- Earning Date
- LSB 11-22-2024
- MYNA 11-19-2024
- Dividend Yield
- LSB N/A
- MYNA N/A
- EPS Growth
- LSB N/A
- MYNA N/A
- EPS
- LSB N/A
- MYNA N/A
- Revenue
- LSB $79,415,311.00
- MYNA $5,957,776.00
- Revenue This Year
- LSB $39.33
- MYNA $216.03
- Revenue Next Year
- LSB $75.61
- MYNA $267.22
- P/E Ratio
- LSB N/A
- MYNA N/A
- Revenue Growth
- LSB N/A
- MYNA 21.89
- 52 Week Low
- LSB $1.88
- MYNA $0.66
- 52 Week High
- LSB $11.20
- MYNA $7.58
- Technical
- Relative Strength Index (RSI)
- LSB 43.57
- MYNA 52.95
- Support Level
- LSB $1.91
- MYNA $1.42
- Resistance Level
- LSB $3.23
- MYNA $1.46
- Average True Range (ATR)
- LSB 0.55
- MYNA 0.11
- MACD
- LSB 0.16
- MYNA 0.01
- Stochastic Oscillator
- LSB 53.57
- MYNA 74.42
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
About MYNA Mynaric AG American Depository Shares
Mynaric AG operates in the communication equipment business sector. The company is engaged in the manufacture and sale of products and projects and the provision of services in the field of laser technology, in particular in the aerospace, telematics, and satellite services sectors. It operates in two segments: Air and Space. The space segment comprises CONDOR terminals, and the Air segment comprises HAWK terminals. The company's product portfolio consists of Optical ground stations, Air-to-ground terminals, Air-to-air terminals, Space terminals, and Custom products and subcomponents. Its applications consist of high-altitude networks, remote eyes, satellite constellations, earth observation satellites, and others. Geographically, its key revenue is derived from the United States.